http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013040181-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb7ce8745175865c6357f7d5fe7fccf5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate | 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac1aaf648fdf580703ce3971b3372b51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecbf81ca42abe7dd7ae2f0d648be9d68 |
| publicationDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013040181-A |
| titleOfInvention | Periodic progestin regimens and kits |
| abstract | A method of contraception is provided. (A) a first phase in which a daily dosage unit of an agonist is administered for 21 to 27 days, each daily dosage unit containing an effective amount of an agonist comprising a progestin; and (b) an effect. Use of progestins in the manufacture of a medicament useful for contraception in fertile females, wherein a medicament comprising a second period of 1 to 7 days without administration of an effective amount of the medicament is administered over 28 consecutive days. Progestins include 17-hydroxyprogesterone ester, 19-nor-17-hydroxyprogesterone ester, 17α-ethynyltestosterone and its derivatives, 17α-ethynyl-19-nor-testosterone and its derivatives, norethindrone, norethindrone acetate, etinodiol diacetate, didrogesterone , Medroxyprogesterone acetate, norethinodrel, allylestrenol, linestrenol, finestanol acetate, and the like. [Selection figure] None |
| priorityDate | 2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.